New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
about
Advances in diagnostic and treatment modalities for intracranial tumors.Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell CarcinomaFrame-Based Stereotactic Biopsy of Canine Brain Masses: Technique and Clinical Results in 26 Cases.Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.Canine brain tumours: a model for the human disease?IL13RA2 targeted alpha particle therapy against glioblastomas.Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors.An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.Expression and targeting of transcription factor ATF5 in dog gliomas.Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs.Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas.Dogs are man's best friend: in sickness and in health.Coarse particulate matter (PM2.5-10) in Los Angeles Basin air induces expression of inflammation and cancer biomarkers in rat brains.Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas
P2860
Q30358150-4B8E6DA6-A404-4D88-929F-B01695AF82F8Q35675548-779AE442-0D3B-4842-B4B1-C2E7C268571CQ36353272-1B47880F-785E-42F3-9EAF-EA4DEC1F1ED5Q37019743-6D131BAA-A03E-411F-A873-9EFFF2141B29Q38491009-F1E16EB6-078C-4084-8DE8-5E735640B8A5Q38754116-4BFE9BDB-F6A3-401F-94FC-94030ED22AB2Q38834470-518281E3-2CBF-4247-B3CD-49F8F27C17C3Q42134236-C12551F5-4335-425C-9B2E-9F7669E1B47EQ45867084-B616DA66-4433-4DB2-AA54-D5195EBCDE27Q46066778-192F5D95-AE50-48BA-B283-9D792BF1994BQ46280771-18F433A9-2B3A-4C9E-8E4A-DDEC3586A1D4Q47866350-0F675776-036C-49D7-8194-B2E6AA9C0821Q48679475-48B2D2DC-A738-47DF-A231-81D3DFD02D71Q55042850-716573CA-CCEF-4F61-A502-6B6E2E141F70Q57300937-54FFE092-347E-493F-ACA3-1981E98D69FA
P2860
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@ast
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@en
type
label
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@ast
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@en
prefLabel
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@ast
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@en
P2093
P2860
P1433
P1476
New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
@en
P2093
Denise M Gibo
John H Rossmeisl
John Robertson
Peter Dickinson
Waldemar Debinski
P2860
P304
P356
10.1371/JOURNAL.PONE.0077719
P407
P577
2013-10-16T00:00:00Z